Accurate Prediction of Dose-Dependent CYP3A4 Inhibition by Itraconazole and Its Metabolites From In Vitro Inhibition Data

Por Templeton, I, Peng, C-C, Thummel, KE, Davis, C, Kunze, KL, Isoherranen, N
Publicado em 2010

Genetic Risk Factors for Major Bleeding in Patients Treated With Warfarin in a Community Setting

Por Roth, JA, Boudreau, D, Fujii, MM, Farin, FM, Rettie, AE, Thummel, KE, Veenstra, DL
Publicado em 2014

Associations between Diet and Cardiometabolic Risk among Yup’ik Alaska Native People using Food Frequency Questionnaire Dietary Patterns

Por Ryman, TK, Boyer, BB, Hopkins, S, Philip, J, Beresford, SAA, Thompson, B, Heagerty, PJ, Pomeroy, JJ, Thummel, KE, Austin, MA
Publicado no Nutr Metab Cardiovasc Dis (2015)

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

Por Birdwell, KA, Decker, B, Barbarino, JM, Peterson, JF, Stein, CM, Sadee, W, Wang, D, Vinks, AA, He, Y, Swen, JJ, Leeder, JS, van Schaik, RHN, Thummel, KE, Klein, TE, Caudle, KE, MacPhee, IAM
Publicado no Clin Pharmacol Ther (2015)